S100A8, S100A9, and S100A8/A9 are damage-associated molecular pattern molecules [46], which are highly elevated in patients suffering from atopic dermatitis [47–49] and can be detected in some inflammatory reactions in activated keratinocytes [50]. The gene discussed is S100A9; the disease is atopic eczema.